<DOC>
	<DOCNO>NCT02226822</DOCNO>
	<brief_summary>This study intend prospectively research treatment reality long-term disease control Type 2 Diabetes Mellitus ( T2DM ) patient initiate 2nd line anti-diabetes treatment site across Japan .</brief_summary>
	<brief_title>DISCOVERing Treatment Reality Type 2 Diabetes Real World Setting Japan</brief_title>
	<detailed_description>This study single country , multicenter , observational , prospective , longitudinal cohort study include adult patient document history T2DM initiate second line oral parenteral anti-diabetes mediation first line anti-diabetic therapy real world setting . The follow-up period 3 year . Patients undergo clinical assessment receive standard medical care determine treat physician . Patients receive experimental intervention experimental treatment consequence participation study .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>1 . Written consent obtain 2 . Aged &gt; = 20 year 3 . Diagnosed type 2 diabetes mellitus 4 . Initiating second oral parenteral antidiabetic therapy add oral antidiabetic monotherapy switch monotherapy another monotherapy different drug class 1 . Diagnosis Type 1 Diabetes Mellitus 2 . Current pregnancy 3 . Current treatment cancer 4 . Current dialysis treatment renal transplantation 5 . Current treatment oral steroid 6 . Participation randomize control trial 7 . Presence condition/circumstance opinion investigator could significantly limit complete follow patient ( e.g . tourist , nonnative speaker understand local language interpreter available , psychiatric disturbance , alcohol drug abuse ) .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Type 2 diabetes mellitus</keyword>
</DOC>